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Abstract
Background: In specialized cells, such as mast cells, macrophages, T lymphocytes and Natural
Killer cells in the immune system and for instance melanocytes in the skin, secretory lysosomes
(SL) have evolved as bifunctional organelles that combine degradative and secretory properties.
Mutations in lysosomal storage, transport or sorting molecules are associated with severe
immunodeficiencies, autoimmunity and (partial) albinism. In order to analyze the function and
content of secretory lysosomes in different cell populations, an efficient enrichment of these
organelles is mandatory.
Results: Based on a combination of differential and density gradient centrifugation steps, we
provide a protocol to enrich intact SL from expanded hematopoietic cells, here T lymphocytes and
Natural Killer cells. Individual fractions were initially characterized by Western blotting using
antibodies against an array of marker proteins for intracellular compartments. As indicated by the
presence of LAMP-3 (CD63) and FasL (CD178), we obtained a selective enrichment of SL in one
of the resulting organelle fractions. The robustness and reproducibility of the applied separation
protocol was examined by a high-resolution proteome analysis of individual SL preparations of
different donors by 2D difference gel electrophoresis (2D-DIGE).
Conclusion: The provided protocol is readily applicable to enrich and isolate intact secretory
vesicles from individual cell populations. It can be used to compare SL of normal and transformed
cell lines or primary cell populations from healthy donors and patients with lysosomal storage or
transport diseases, or from corresponding mutant mice. A subsequent proteome analysis allows
the characterization of molecules involved in lysosomal maturation and cytotoxic effector function
at high-resolution.
Background
Cytotoxic T lymphocytes (CTL) and Natural Killer (NK)
cells deliver their cytolytic effector molecules via so-called
secretory lysosomes (SL). These organelles contain a
number of cytotoxic proteins and undergo regulated
secretion in response to external stimuli, for example to
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eliminate virus-infected and tumorogenic cells by the
induction of apoptosis. In most eukaryotic cells, lyso-
somes are acidic organelles equipped with hydrolases to
degrade and recycle endogenous or exogenous biomole-
cules [1]. Interestingly, in various hematopoietic cell line-
ages associated with secretory effector functions (CTL, NK,
mast cells and macrophages), a subset of lysosomes
gained a second function as a storage and transport vehi-
cle for effector molecules [2,3]. Similarly, outside the
immune system, melanocytes utilize a comparable
organelle to regulate pigmentation [4].
In mast cells, histamine and serotonin are the key factors
associated with SL, whereas in macrophages, for example
MHC molecules and cytokines are stored and transported
via this compartment [2]. As mentioned, SL of mature T
and NK cells are characterized by the presence of cytotoxic
effector molecules including perforin [5], granzymes [5],
granulysin [6], and the TNF family protein FasL (CD178)
[7,8]. Interestingly, the 'packaging' of individual effector
molecules is quite different. Granzymes and perforins
appear to be stored at least in part in association with car-
rier proteins (e.g. serglycins) in the vesicular lumen to
form dense core particles [9]. In contrast, the FasL is a
transmembrane protein that in fact might be 'directly'
involved in the transport of SL during organelle matura-
tion and effector responses. During maturation, FasL is
transported to SL by SH3 domain proteins interacting
with its proline-rich C-terminus. Subsequently, FasL
might participate in connecting SL to the actin-cytoskele-
ton via its interaction with Nck and associated actin-regu-
latory proteins [10-12].
Genetic diseases based on defects of the secretory machin-
ery such as the Chédiak-Higashi Syndrome (CHS), the
Hermansky-Pudlak Syndrome (HPS) or the Griscelli Syn-
drome (GS) are characterized by a combination of immu-
nodeficiency and albinism, reflecting the close
relationship of the SL-related secretory pathway in hemat-
opoietic cells and melanocytes as non-hematopoietic cells
[4]. Although the genetic defects have been mostly deci-
phered, their influence on the overall protein composi-
tion of secretory lysosomes is not completely understood.
Of note, a number of mouse strains are available that
reflect the pathophysiology in patients. As an example,
LYST-deficient mice are the murine counterpart of CHS
and thus suffer from immunodeficiency and also carry a
respective fur phenotype ('beige mouse'). Cells of such
mice harbor giant lysosomes, indicating that the lyso-
somal maturation and storage might still be operational,
while exocytosis and recycling are severely impaired [13].
For the detailed analysis of the proteomic profile of SL, it
is important to efficiently enrich or purify this compart-
ment from a limited number of cells. In 1978, a first den-
sity gradient centrifugation protocol was developed to
purify organelles from rat hepatocytes using a non-ionic
X-ray contrast compound termed Metrizamide [14]. Com-
pared to traditional sucrose gradients, the advantage of
Metrizamide was a much lower osmolarity that enabled
adequate separation of lysosomes and mitochondria
without artificially altering their density as for instance
observed with Triton WR1339 [15] or dextran [16]. In the
meantime, several non-ionic iodinated density gradient
media have been developed, which are often derivatives
of metrizoic acid, for example Nycodenz and its dimer
Iodixanol (commercially available as OptiPrep™, a 60%
solution of Iodixanol-5,5'- [(2-hydroxy-1,3-propanediyl)-
bis(acetylamino)]bis [N, N'-bis(2,3-dihydroxypropyl-
2,4,6-triiodo-1,3-benzenecarboxamide). The major
advantage of Iodixanol in this context is its ability to form
iso-osmotic solutions at high densities (up to 1.32 g/ml)
[17]. In 1994, Graham et al. first described the usage of
Iodixanol as density gradient media and provided a first
set of subcellular isolation protocols [18,19].
Another standard gradient medium that also offers lower
osmolarity and viscosity is Percoll™. It consists of colloi-
dal silica coated with polyvinylpyrrolidone (PVP). In the
last three decades, Percoll™ gradients were not only used
to separate lymphocyte subpopulations but also to isolate
cytotoxic granules of NK [20,21] and T cell lines [21,22].
Recently, several Percoll-based isolation protocols were
compared with regard to the functionality of effector mol-
ecules in the obtained fractions in cytotoxicity assays [23].
A major disadvantage of Percoll™ as a separation medium
is that silica often has to be removed from the obtained
fractions because it might interfere with downstream
applications. Unfortunately, however, such washing steps
are mostly accompanied by the loss of organelle integrity.
Here, we describe a rapid and reliable Iodixanol-based
subcellular fractionation protocol that allows the substan-
tial enrichment of intact secretory vesicles for example
from in vitro expanded lymphocyte populations. Impor-
tantly, the obtained fractions are compatible with stand-
ard analyses such as Western blotting and even with
CyDye labeling for subsequent high-resolution two-
dimensional difference gel electrophoresis [24].
Results
Subcellular fractionation
For the purification of lysosomal fractions, we applied a
low osmotic medium for density gradient centrifugation.
Following primary organelle enrichment by differential
centrifugation, the subcellular compartments were sepa-
rated on a discontinuous Iodixanol gradient (Figure 1A).
Individual fractions were collected from the top of the gra-
dient and the protein content of the six obtained fractions
(Figure 1B) was quantified using a Bradford protein assay.
Equal amounts of protein were then separated by SDS-
PAGE and analyzed by Western blotting for the presenceBMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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of characteristic organelle marker proteins (Figure 2). In
order to define the major lysosomal fraction, Western
blots were stained for CD63 (LAMP-3 or LIMP) and
CD107a (LAMP-1) as classical lysosome-associated mem-
brane proteins and for CD178 (FasL) and perforin as char-
acteristic marker proteins for secretory lysosomes of T and
NK cells [3,25]. In addition, we stained for Vti1b, a mem-
brane-bound SNARE protein that is thought to function
in the regulation of post-Golgi vesicle trafficking and
secretory pathways [26]. As detailed in Figure 2A, all puta-
tive marker proteins for secretory lysosomes and also
Vti1b were enriched in fraction 2 of the final Iodixanol
gradient. At the same time, this putative secretory lyso-
somal fraction 2 did not contain Golgin84, a marker for
Golgi cisternae [27], or CoxIV as a marker for mitochon-
dria [28], or catalase as an indicator for peroxisomes [29].
Furthermore, all Iodixanol fractions were not stained with
an anti-pan-cadherin antibody indicating that they are
devoid of contaminating plasmamembrane fragments
that were readily removed during the first differential cen-
trifugation step. It should be mentioned, however, that
organelle separations by density gradients should not be
regarded as purifications but rather as enrichment proce-
dures. Following our protocol, we thus found Bip/Grp78,
a marker for the endoplasmic reticulum [30], and EEA-1,
a marker for early endosomes [31] as 'contaminants' in
the putative lysosomal fraction 2. Interestingly, granzyme
B and granulysin, two cytotoxic effector molecules that are
known to be present in secretory vesicles [5,6] were also
present in other fractions. In case of granulysin, the long
(premature) form of 15 kDa was selectively enriched in
fraction 2 whereas the mature form (9 kDa) was detected
in all fractions with the highest abundance in fractions 4
and 6. Similarly, granzyme B was detected in fractions 2–
6, again with the strongest signals after Western blotting
in fractions 4 and 6. Most importantly, however, if puta-
tive SL were enriched from different FasL-containing cell
populations, including stable Jurkat transfectants (JFL), in
Purification of enriched secretory lysosomes Figure 1
Purification of enriched secretory lysosomes. A. 
Enriched organelle fractions (EO) were adjusted to 19% (v/v) 
OptiPrep® and loaded in the middle of the discontinuous 
density gradient. B. After 5 h of ultracentrifugation, six indi-
vidual fractions became apparent at the individual interphases 
that were collected, pelleted and used for subsequent analy-
ses.
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Representation of marker proteins in individual OptiPrep®  fractions Figure 2
Representation of marker proteins in individual Opti-
Prep® fractions. A. The individual lanes represent whole 
cell lysate (WL), enriched organelles (EO) and six individual 
fractions collected after density gradient centrifugation of 
PHA blasts expanded for 14 days. The blots were analyzed 
for the presence of known organelle marker proteins as indi-
cated. One representative Western blot of four performed 
experiments with different T cell blasts is shown. B. An 
enrichment of FasL (as a marker protein for secretory lyso-
somes) is detected in fraction 2 of different lymphocyte sub-
populations including CD4+ and CD8+ T cells, in vitro 
expanded human NK cells and the stably FasL-transfected 
Jurkat variant JFL.
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vitro expanded CD4+ and CD8+ T cells, or NK cells, we con-
sistently noted a substantial enrichment of this marker
protein in the respective fraction 2 (Figure 2B).
Electron micrographs of isolated vesicles
To verify whether the obtained fractions contain intact
vesicles, isolated granules of 13 days old PHA blasts corre-
sponding to fractions 2 and 6 were fixed and processed for
electron microscopical inspection as detailed in the Mate-
rial and Methods section. As shown in Figure 3, round
membrane-enclosed organelles with a characteristic elec-
tron density and a diameter between 250 and 700 nm
formed a predominant organelle population in fraction 2
(Figure 3A, B). In contrast, the predominant structures in
fraction 6 were slightly smaller, membrane-enclosed and
somehow polar vesicles that were mainly characterized by
a much higher electron density (Figure 3C, D).
2D-DIGE of enriched secretory granules
In order to analyze the robustness of our purification pro-
tocol, PHA-stimulated lymphocytes of two healthy
donors were expanded in vitro for 16 days. After differen-
tial and density gradient centrifugation, the obtained
organelles of fraction 2 were pelleted and lyzed in 2D lysis
buffer. For the subsequent 2D-DIGE analysis, 50 μg of
enriched SL (= fraction 2) of donor 1 were labeled with
Cy5 and 50 μg of SL of donor 2 with Cy3. The samples
were combined, spiked with 50 μg each of unlabeled frac-
tion 2 protein and subjected to isoelectric focusing on an
IPG strip (pH 3–11 NL) in the first dimension and a con-
ventional SDS-PAGE (12.5% gel) for the second dimen-
sion. A characteristic protein distribution along with the
initial analysis using the DeCyder® software package is
shown in Figure 4. As indicated by the yellow color in the
overlay (Figure 4A), the two fractions were extremely sim-
ilar although the original cells were derived from two dif-
ferent donors, expanded for more than two weeks and
both samples were isolated on separate gradients. The
high reproducibility of the lysosomal enrichment using
individual biological samples is also reflected in the
graphical depiction of the spot distribution (Figure 4B).
Using standard settings, of the 972 included proteins, 34
were marked different with a threshold set to 1.7 fold and
only 7 with a threshold set to 3 fold. Of note, a threshold
of 1.7 is equivalent to a two-fold square deviation of the
spot volumes and results in a variance of approximately
3.5% of the calculated protein content.
Peptide mass fingerprinting of selected spots
In order to identify selected differentially represented
spots by peptide mass fingerprinting (PMF), individual
spots were automatically picked using an Ettan Spot-
picker. Tryptic digestion was performed as described
before [32] and eluted peptides were dried, resuspended
in MALDI matrix and spotted on MALDI targets. The sub-
sequent PMF analyses revealed differences for example in
MHC class II molecules (#1; α-chain -2.13 fold), gelsolin-
like capping protein isoforms (#2; -3.03 and #4; 8.98
fold) and in chaperonin containing TCP1, subunit 8 (#3;
2.63 fold) between the two samples (Table 1 and
Figure 5).
Similarity of individual SL preparations
We also wanted to know whether enriched secretory lyso-
somes of individual T cell subpopulation show a compa-
rable protein pattern. To this end, we isolated CD4+ T cells
of three different donors by magnetic-activated cell sort-
ing. Individual fraction 2 samples were compared by 2D
electrophoresis on separate gels stained with Flamingo
Pink. Scanning, data acquisition and individual intra-gel
comparisons using the Image Master 6.0 software package
again revealed a highly similar protein pattern in all sam-
ples (Figure 6). The average correlation coefficient in scat-
ter plot images was 0.95 (Figure 6B). Of note, this
coefficient can vary between -1 and 1, with an absolute
value of 1 indicating the perfect fit. As a conclusion, the
proteomic profiles of enriched fraction 2 SL of separately
expanded CD4+  T cell populations of three different
donors are indeed very similar with only a few proteins
being differentially expressed.
Electron micrographs of isolated secretory granules Figure 3
Electron micrographs of isolated secretory granules. 
Enriched granules of PHA blasts corresponding to fraction 2 
(A, B) or fraction 6 (C, D) were fixed and embedded in arald-
ite. Overview pictures are given in A and C, higher magnifica-
tions in B and D. (Bar, 250 nm)
A
B
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2D-DIGE analysis of enriched SL of PHA blasts from two different donors Figure 4
2D-DIGE analysis of enriched SL of PHA blasts from two different donors. A. Fifty μg of fraction 2 protein were 
labeled with Cy3 (donor 1, green channel) or Cy5 (donor 2, red channel), respectively and spiked with unlabelled protein. Yel-
low indicates comparable abundance of proteins in both samples. One representative experiment of two performed with 
unseparated PHA blasts is shown – more experiments were performed with lymphocytes subpopulations. B. Statistical repre-
sentation of the overall protein distribution in individual samples. The red line indicates the number of spots with a specific 
abundance ratio (log scale). The blue line represents the calculated Gaussian distribution. Red dots represent decreased and 
blue increased protein content in individual spots detected in both samples (considered from Cy3 → Cy5). The threshold was 
set to 1.7. C, D. Individual images corresponding to the individual samples of donor 1 (C) and donor 2 (D), respectively. Differ-
ential spots are marked either red or blue reflecting the color-coding in B. The numbers displayed in B and C correspond to 
the numbers in Figure 5 and table 1.
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Discussion
In the present study we describe a reliable protocol for the
enrichment of intact secretory vesicles for the subsequent
detailed analysis of this subcellular compartment. Combi-
nations of differential and density gradient centrifugation
procedures are widely used to isolate organelle fractions.
Iodinated, low osmotic media are advantageous in this
context not only because of their low osmolarity but also
because they lack silica, which might interfere with
organelle integrity and subsequent analyses. Since the
density of lysosomes might vary depending on the cell or
tissue type, an optimization of gradient sizes and concen-
trations, as well as centrifugation setting is required to
obtain reproducible results. We optimized this protocol
for the rapid and reproducible enrichment of secretory
lysosomes of lymphocyte subpopulations. Using this
methodology, we already defined the SL proteome of NK
cell lines and primary NK cells [32]. In the present study,
we tested the reproducibility and reliability of the proce-
dure by comparing purified SL fractions of polyclonal
activated T cell populations (PHA blasts) and subpopula-
tions (CD4+ T cells) of different donors by subsequent
Western blotting and high-resolution 2D difference gel
electrophoresis. We show that the SL fractions of T cells
Table 1: Selected proteins identified by peptide mass fingerprinting.
spot # protein name Vol. ratio NCBI Acc.No. MW pI identified peptides MASCOT score
1 MHC class II alpha chain -2.13 gi|3212400 20548 4.9 3 113
2 capping protein (actin filament), gelsolin-like -3.03 gi|63252913 38760 5.8 9 334
3 chaperonin containing TCP1, subunit 8 2.63 gi|48762932 60153 5.4 5 183
4 capping protein (actin filament), gelsolin-like 8.98 gi|55597035 38779 5.9 9 368
Selected differential spots in SL preparations of two different donors Figure 5
Selected differential spots in SL preparations of two different donors. 3D images of differentially expressed proteins 
in the lysosomal preparations of donor 1 and donor 2. Two proteins (#1: MHC class II alpha chain and #2: capping protein 
(actin filament), gelsolin-like) are reduced in donor 2 (A) and two proteins (#3: chaperonin containing TCP1, subunit 8 and #4: 
capping protein (actin filament), gelsolin-like) are reduced in donor 1 (B). The bold grey line indicates the same location in both 
images. The intensity of the spot is indicated by the 3D views. Spots #2 and #4 presumably represent isoforms of the gelsolin-
like capping protein.
#1
#4
#2
#3
donor 1 donor 2 A
B
gelsolin-like 
capping protein
gelsolin-like 
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-chain 
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TCP1BMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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from healthy donors are very similar with regard to the
overall protein content, with only minor differences in
MHC molecules or associated transporter proteins or
chaperons. Thus, this methodology is apparently ideal as
basis for the detailed investigation of consequences of
genetic alterations associated with lysosomal transport
and storage diseases.
One initial key step of organelle preparation is the disrup-
tion of the cells. We applied a mild dounce homogeniza-
tion and empirically determined the number of strokes
for optimal cell opening with minimal damage to
organelles and nuclei by trypan blue staining. The first
centrifugation step efficiently removed intact cells, nuclei
(data not shown) and associated plasma membrane frag-
ments (Figure 2). Since mitochondria are more sensitive
to hydrostatic pressure [33], bottom loading of density
gradients caused an increase in their density relative to
that of lysosomes. As reported before, we also noted that
in iodinated density gradient media such as Iodixanol,
lysosomes tend to better separate from mitochondria or
peroxisomes than in silica-based percoll media [19].
The interphases containing individually enriched
organelles can be removed from the top of the gradient or
by perforation of the centrifugation tube with a suitable
needle. We routinely collected the samples from the top of
the tubes. In our study, the individual fractions were ana-
lyzed by Western blotting for the presence of marker pro-
teins for secretory lysosomes (CD63 (LAMP-3), CD107a
(LAMP-1) and CD178 (FasL)), mitochondria (Cox IV),
peroxisomes (catalase), ER (Bip/Grp78), Golgi
(Golgin84) and early endosomes (EEA-1). Although con-
taminations of lysosomal fractions with mitochondria
often hamper analyses of lysosomes obtained by density
gradient centrifugation, the use of a discontinuous Iodix-
anol® separation gradient resulted in a clear separation of
Cox IV containing mitochondria (fraction 5) and secre-
tory lysosomes characterized by the presence of LAMP-1,
CD63 and FasL (fraction 2). Besides the enrichment of
FasL and lysosomal membrane proteins, which is indica-
tive for the enrichment of SL in fraction 2, we observed a
rather high abundance of other cytotoxic effector mole-
cules (including granzyme B, perforin and granulysin) in
fractions 4 and 6 (Figure 2). The presence of effector mol-
Similarity of protein content in SL of different CD4+ cell lines Figure 6
Similarity of protein content in SL of different CD4+ cell lines. A. Isolated SL (fraction 2) of CD4+ cells from 3 different 
donors were separated on individual gels and stained with Flamingo Pink. B. Statistical analysis of spot intensities between the 3 
donors using Image Master software revealed a highly similar protein pattern as indicated by the regression line and the corre-
lation coefficient.
A
B
pH 31 1 pH 31 1 p H 31 1
donor 1 donor 2 donor 3
donor 1
donor 2
donor 3
donor 2BMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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ecules in separate intact electron dense fraction 6 granules
(Figure 3) was unexpected. Employing the separation
method described here, we are currently investigating and
comparing the composition of the two vesicular structures
in different T and NK cell populations in more detail. We
think that the distinct SL/granules actually form two sep-
arate compartments that might arise from an initial mul-
tivesicular complex during vesicular maturation. Fractions
2 and 6 not only differ substantially in the content of
effector molecules but also in proteins that regulate
cytoskeletal association (Schmidt et al., unpublished). Of
note, since the described purification protocol does not
imply nucleases and results in intact granules as shown by
electron microscopy (Figure 3), enriched SL (and also
fraction 6 granules) should be suitable to assay their
capacity to directly induce target cell apoptosis by stand-
ard DNA fragmentation or chromium release assays as
described before by Trapani and colleagues [23].
Importantly, the relatively high number of cells (we rou-
tinely started with 400 × 106) needed as an input for the
enrichment of secretory vesicles is easily achievable if one
wants to analyze leukemic cell lines or murine or human
T cell or NK cell populations. To demonstrate the repro-
ducibility and reliability of this technique, we isolated
enriched secretory lysosomes of PHA stimulated lym-
phocytes of two different donors and compared these frac-
tions by 2D-difference gel electrophoresis. This direct
comparison at high-resolution revealed an almost identi-
cal spot pattern (96.5% at a threshold of 1.7), indicating
that the presence and also the abundance of the approxi-
mately 1000 individual proteins in these enriched frac-
tions are highly conserved in biological replicates. To
stress this point: if one compares the different fractions
from one donor, the protein content is completely differ-
ent (21.4% comparable proteins in fractions 2 and 5 at a
threshold of 1.7).
Since we were interested in the few differences between
the two samples, we picked four selected spots and iden-
tified the proteins by mass spectrometry. Although only
200 μg of total protein were separated on the respective
gels, even low abundant spots (#1, #3) were identified. It
is important to mention that spot picking was performed
from Flamingo Pink stained gels since we and others
noted that CyDye minimal labeling results in significant
alterations of protein masses, especially of low molecular
weight proteins [34]. Since only 3% of a given protein is
labeled by the employed minimal labeling procedure,
97% of the protein might be actually located below the
initially detected protein spot. Nonetheless, the subse-
quent PMF analyses revealed differences in MHC class II
molecules, gelsolin-like capping protein isoforms and in
chaperonin containing TCP1, subunit 8 between the two
samples (Figure 5). Without going into further details,
these or related proteins have been associated with secre-
tory vesicles in other studies before [35]. In a recent study,
we provided a detailed analysis of the proteome of
enriched SL from different NK cell lines and primary NK
cells [32]. We identified roughly 400 protein spots repre-
senting 237 individual proteins. As a proof of principle,
although in NK cells the overall protein content of iso-
lated SL was also very similar, we described a heterogene-
ous profile of functionally relevant proteins in leukemic
and primary NK cells.
The reliability of the presented protocol is further stressed
by the comparison of SL from CD4+ T cells isolated from
three different donors. Of note, most CD4+ T cells also
gain cytotoxic potential associated with SL when
expanded in vitro [11]. As expected from the initial 2D-
DIGE experiments on PHA blasts, also standard 2D gel
electrophoresis followed by Flamingo Pink staining and
indirect comparison of individual gels using Image Master
software revealed a very high degree of similarity between
the individual fraction 2 preparations (Figure 6). This
notion is highly relevant since future proteome analyses
need to be standardized and suitable to compare appro-
priate numbers of samples for statistical analyses [36].
Conclusion
We describe a reliable, reproducible and easy to perform
method for the enrichment of secretory lysosomes. We
demonstrate that enriched SL fractions of individual
donors or lymphocyte subpopulations are almost identi-
cal in their overall protein content. We thus provide a
standard protocol for the future comparison of this
important compartment in different T and NK cell sub-
populations, in untransformed and transformed cells, and
in T and NK cell populations of patients or mice suffering
from genetically caused lysosomal storage diseases. Fur-
thermore, the protocol might be easily adapted to investi-
gate lysosomes of other cellular origin, including
macrophages, mast cells or melanocytes.
Methods
Cells
Human peripheral blood mononuclear cells (PBMC)
were isolated from buffy coat preparations by Ficoll
(1.077 g/ml) density gradient centrifugation. CD4+, CD8+
or NK cells were further purified by magnetic-activated
cell sorting from PBMC (MACS Cell Isolation Kits,
Miltenyi, Bergisch Gladbach, Germany) and adjusted to
106 cells/ml in RPMI 1640 supplemented with 10% FCS
for CD4+ and CD8+ or with 10% heat-inactivated pooled
AB human serum for NK cells. All isolated cells were
expanded in the presence of a feeder cocktail of irradiated
EBV-transformed B cells and PBMCs. For the generation of
PHA blasts, PBMC were adjusted to 106 cells/ml in RPMI
1640 supplemented with 5% heat-inactivated FCS and 0.5BMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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μg/ml phytohemagglutinin A (PHA) (Remel, Lenexa, KS,
USA). After 4 days of stimulation, dead cells were
removed by Ficoll gradient centrifugation. All cell cultures
were maintained at a cell density of 1.5–2.0 × 106 cells/ml
for up to 3 weeks in the presence of 1000 U/ml human
recombinant interleukin 2 (rIL-2, Chiron GmbH, Mar-
burg, Germany) for NK cells and 100 U/ml for CD4+ and
CD8+ T cells, respectively. All culture media contained
penicillin (50 U/ml) and streptomycin (50 μg/ml). Cell
culture was performed at 37°C in a humidified atmos-
phere with 5% CO2.
Subcellular fractionation
For subcellular fractionation and enrichment of secretory
lysosomes from PHA-blasts, 4 × 108 cells were used. The
cells were centrifuged, washed once with ice-cold PBS and
resuspended in 2.5 ml extraction buffer including a pro-
tease inhibitor cocktail (Sigma, St Louis, MO, USA). Gra-
dient media and buffers were purchased as a kit from
Sigma or made up according to Graham [19]. The cells
were disrupted in a dounce glass homogenizer with a
small clearance pestle using 25 strokes. For the initial
enrichment of organelles, the homogenates were sepa-
rated by centrifugation at 1,000 × g for 10 min to pellet
nuclei and remaining intact cells. The postnuclear super-
natant was sedimented at 20,000 × g for 20 min. The
resulting pellet was adjusted to 19% (v/v) Optiprep®
(Sigma), loaded in the middle of a non-ionic, low osmotic
discontinuous density gradient with 27%, 22.5%, 19%,
16%, 12%, 8% Optiprep®, and subjected to an ultracen-
trifugation at 150,000 × g for 5 h. The osmolarity was
adjusted to 290 mOsm with 2.3 M sucrose. The subcellu-
lar fractions were collected from the top of the tube,
washed and concentrated with HB-Buffer (250 mM
sucrose, 10 mM Hepes pH 7.3; and 0.3 mM EDTA) at
150,000 × g for 20 min. All ultracentrifugation steps were
carried out at 4°C in Ultra-Clear centrifugation tubes in a
swing-out rotor (SW60Ti, Beckman Coulter, Krefeld, Ger-
many). The protein content of the individual fractions
was determined using a Coomassie-based protein assay
(Pierce, Rockford, IL, USA). Starting with 400 × 106 cells,
homogenized in 2.70 ml of homogenization buffer, the
enriched organelle fraction contained about 1.35 mg of
protein (table 2). After density gradient centrifugation, the
mean protein concentration in individual fractions was
0.324 mg/ml for fraction 1, and 0.398 mg/ml, 0.889 mg/
ml, 0.490 mg/ml, 0.905 mg/ml and 0.379 mg/ml for frac-
tions 2 to 6. Corresponding to the volume of individual
fractions (200 μl for fractions 1, 5 and 6, 300 μl for frac-
tions 3 and 4, and 400 μl for fraction 2) the recovery was
calculated as detailed in table 2.
Transmission electron microscopy
Enriched granules of fractions 2 and 6 were fixed with
2.5% glutaraldehyde in PBS at 4°C overnight, washed in
PBS, postfixed in 2% OsO4, dehydrated in ethanol, and
embedded in araldite (Sigma). Thin sections were
mounted on formvar-coated grids and double-stained
with a saturated solution of uranyl acetate in 70% metha-
nol and with lead citrate. The grids were examined with a
Zeiss EM 900 transmission electron microscope.
SDS-PAGE and Western blotting
For Western blot analysis, 4 μg of protein per fraction were
separated by SDS-PAGE on 4–12% gradient Bis-Tris gels
(Invitrogen, Karlsruhe, Germany). After blotting to 0.2
μm nitrocellulose membranes (Biometra, Goettingen,
Germany), protein loading and efficacy of transfer was
checked by reversible staining with Ponceau S (not
shown). Membranes were routinely blocked with 5%
non-fat dry milk powder or bovine serum albumin in
TBST (TBS + 0.05% Tween), respectively. The fractions
were analyzed with anti-FasL monoclonal antibody
(mAb) clone G-247.4 (1/1000, BD Bioscience, San Diego,
CA, USA), anti-LAMP-1 mAb clone 25 (1/500, BD Bio-
sciences), anti-CD63 mAb clone MEM-259 (1/1000,
Acris, Hiddenhausen, Germany), anti-Perforin mAb clone
B-D48 (1/500, Abcam, Cambridge, UK), anti-Vti1b mAb
Table 2: Total protein and protein concentrations in individual fractions obtained after differential and density centrifugation.
fraction Exp. 1 Exp. 2 Exp. 3 Exp. 4 mean SD Volume protein
[mg/ml] [mg/ml] [mg/ml] [mg/ml] [mg/ml] [μl] [μg]
homogenate 3.891 3.222 3.532 3.684 3.582 0.282 2700 9671.4
enriched organelles (input) 0.745 0.651 0.729 0.865 0.747 0.088 1800 1345.3
fraction 1 0.349 0.303 0.347 0.296 0.324 0.028 200 64.7
fraction 2 0.430 0.468 0.306 0.389 0.398 0.069 400 159.3
fraction 3 0.764 0.909 1.004 0.879 0.889 0.099 300 266.7
fraction 4 0.526 0.548 0.480 0.405 0.490 0.063 300 147.0
fraction 5 0.925 0.882 0.959 0.852 0.905 0.047 200 180.9
fraction 6 0.384 0.431 0.352 0.349 0.379 0.038 200 75.8
recovery 894.4BMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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clone 7 (1/1000, BD Biosciences), anti-Golgin84 mAb
clone 26 (1/250, BD Biosciences), anti-CoxIV mAb clone
10G8D12C12 (1/1000, MitoScience, Eugene, OR, USA),
anti-granzyme B mAb clone 2C5/F5 (1/2000, BD Bio-
sciences), anti-EEA-1 mAb clone 14 (1/2500, BD Bio-
sciences), anti-Bip/Grp78 mAb clone 40 (1/250, BD
Biosciences), anti-pan-Cadherin mAb clone 22744 (1/
1000, Abcam), and horseradish peroxidase (HRP)-conju-
gated goat anti-mouse secondary antibody (1/7500, GE
Healthcare, Uppsala, Sweden). For reprobing, membranes
were stripped in stripping solution (100 mM 2-mercap-
toethanol, 2% SDS, 60 mM Tris) for 30 min at 56°C. The
polyclonal antibodies anti-catalase (1/5000, Abcam) and
anti-granulysin (1/1000, RnD Systems, Minneapolis, MN,
USA) were detected with HRP-conjugated goat anti-rabbit
antibodies and donkey anti-goat, respectively. ECL
(enhanced chemiluminescence) reagents (GE Healthcare)
were used for chemiluminescent detection using Hyper
Film (GE Healthcare).
2D-DIGE
Pelleted fractions were lyzed on ice for at least 30 min
with 30 μl lysis buffer (pH 8.5) containing 7 M urea, 2 M
thiourea, 30 mM Tris and 4% CHAPS [37]. The superna-
tant was removed after centrifugation for 20 min at 20000
× g at 4°C. 50 μg of protein per sample were labeled on
ice with 400 pmol of Cy3 or Cy5 (CyDyes, GE Healthcare)
for 30 min in the dark. After quenching the labeling reac-
tion with 1 μl lysine (10 mM) for 10 min on ice, the dif-
ferentially labeled samples were pooled with 50 μg of
unlabeled protein of each sample and mixed with a dou-
ble volume of rehydration buffer (7 M urea, 2 M thiourea,
4% CHAPS, 2% (v/v) IPG buffer pH 3–11 and 2% (w/v)
DTT). The mixed samples were applied by cup-loading
onto 24 cm IPG non-linear pH 3–11 gel strips, which had
been rehydrated at 20°C for at least 10 h in 450 μl
DeStreak solution (GE Healthcare) with 0.5% (v/v) IPG
buffer pH 3–11 NL. Isoelectric focusing (IEF) was carried
out for a total of 50–55 kVh at 20°C in five steps with a
gradual increase of voltage (150 V for 3 h, 300 V for 4 h,
gradient from 300 V to 1000 V for 6 h, gradient from 1000
V to 10000 V for 3.5 h and 10000 V ~3 h) using the IPG-
phor 3 system (GE Healthcare). For the second dimen-
sion, the IPG strips were first reduced for 15 min in SDS-
equilibrium buffer (6 M urea, 50 mM Tris-HCl, pH 8.8,
30% glycerol, 2% SDS, trace of bromophenol blue and
0.5% (w/v) DTT) and then carbamidomethylated for 15
min in the same buffer containing 4.5% (w/v) iodoaceta-
mide instead of DTT. The second dimension was per-
formed on 12.5% polyacrylamide gels (20 × 24 cm) using
the Ettan Dalt six system (GE Healthcare) at 10 mA per gel
for 1 h, and then with an increased current of 15 mA per
gel until the bromophenol blue band reached the end of
the gel cassette. Electrophoresis was carried out under
continuous cooling at 20°C.
Image analysis and spot picking
The in-gel fluorescence was scanned on a Typhoon Trio
(GE Healthcare) at appropriate wavelengths to detect Cy3
and Cy5 specific emission corresponding to the protein
concentration in every single spot [38]. The intragel spot
detection of the multiplexed gel images was performed
using differential in-gel analysis (DIA) included in the
DeCyder 6.5 software (GE Healthcare). The images for
each gel were merged; spot boundaries were detected fol-
lowed by a normalization of the spot volumes revealing
differential spots. The gels were removed from the glass
plates and stained with Flamingo Pink (Bio Rad) accord-
ing to the manufactures instructions. The post-stained gels
were mounted on a non-backed gel frame, scanned and
analyzed using Image Master 6.0 (GE Healthcare).
Selected spots were picked by an Ettan spotpicker (GE
Healthcare) equipped with a 2 mm picking head accord-
ing to the manufacturer's instructions. The picked gels
were again scanned to verify the correct location of the cut
spots.
In-gel tryptic digestion and mass spectrometry
Gel pieces were washed twice with HPLC grade water
(Roth, Karlsruhe, Germany) and dehydrated in a first step
with 25 mM ammonium bicarbonate (ABC) in 50% ace-
tonitrile (ACN) and shrunk in pure ACN as a second step,
according to [39]. The dry gel pieces were then rehydrated
with 100 ng sequencing-grade trypsin (Serva, Heidelberg,
Germany) in 10 μl of 5 mM ABC. After rehydration, 10 μl
of 5 mM ABC were added. For tryptic in-gel digestion,
samples were incubated overnight at 37°C. To extract the
peptides after the incubation period, 20 μl of 0.3% trif-
luoroacetic acid (TFA) in ACN were added and the sam-
ples were sonicated in a water bath (Sonorex Super
RK100; Bandelin, Berlin, Germany) for 15 min. The liquid
phases were collected, lyophilized, redissolved in 0.5 to 1
μl MALDI matrix solution (3,2 mg/ml α-cyanohydroxy-
cinnamic acid (Sigma) dissolved in 65% ACN/0,1% TFA)
and spotted onto a stainless steel 192-well MALDI plate
and air-dried. The samples were analyzed by peptide mass
finger printing in reflectron mode using the 4700 Pro-
teomics Analyzer mass spectrometer (Applied Biosystems,
Framingham, MA, USA). For MS analyses, typically 750
shots were accumulated for each spot. The peptide mass
spectra were processed by internal calibration with auto-
lytic fragments of porcine trypsin using the GPS Explorer
software version 3.6 (Applied Biosystems) and searched
against human proteins in the NCBI database (191694
entries, 2007/02/28, Homo sapiens) using MASCOT V2.0
(Matrix Sciences, London, UK).
Database analysis
Database searches with MASCOT were performed using
the following parameters: the modification on cysteine
residues by amidomethylation was set as obligate,BMC Immunology 2009, 10:41 http://www.biomedcentral.com/1471-2172/10/41
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methionine oxidation was considered as a potential mod-
ification; the maximum number of missed tryptic cleav-
ages was one; the monoisotopic masses were considered
and the mass tolerance was set to ± 50 ppm.
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